CIP
ELV icon

Chartwell Investment Partners’s Elevance Health ELV Stock Holding History

Chartwell Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.82M Sell
18,893
-4,696
-20% -$2.51M 0.34% 88
2024
Q2 		$12.8M Sell
23,589
-1,379
-6% -$729K 0.45% 51
2024
Q1 		$12.9M Buy
24,968
+2,288
+10% +$1.14M 0.45% 53
2023
Q4 		$10.7M Buy
22,680
+1,342
+6% +$621K 0.38% 91
2023
Q3 		$9.29M Sell
21,338
-1,392
-6% -$631K 0.36% 89
2023
Q2 		$10.1M Buy
22,730
+5,596
+33% +$2.58M 0.37% 86
2023
Q1 		$7.88M Buy
17,134
+2,419
+16% +$1.15M 0.3% 115
2022
Q4 		$7.55M Sell
14,715
-3,757
-20% -$1.91M 0.3% 120
2022
Q3 		$8.39M Buy
18,472
+2,217
+14% +$1.06M 0.36% 103
2022
Q2 		$7.84M Buy
16,255
+3,196
+24% +$1.58M 0.31% 112
2022
Q1 		$6.42M Sell
13,059
-1,004
-7% -$459K 0.21% 169
2021
Q4 		$6.52M Sell
14,063
-3,145
-18% -$1.32M 0.19% 188
2021
Q3 		$6.42M Buy
17,208
+3,441
+25% +$1.31M 0.2% 183
2021
Q2 		$5.26M Sell
13,767
-3,779
-22% -$1.44M 0.15% 202
2021
Q1 		$6.3M Buy
17,546
+2,568
+17% +$826K 0.19% 177
2020
Q4 		$4.81M Sell
14,978
-3,159
-17% -$969K 0.15% 197
2020
Q3 		$4.87M Buy
18,137
+5,653
+45% +$1.52M 0.18% 178
2020
Q2 		$3.28M Sell
12,484
-709
-5% -$189K 0.13% 217
2020
Q1 		$3M Buy
13,193
+1,979
+18% +$539K 0.14% 206
2019
Q4 		$3.39M Sell
11,214
-2,652
-19% -$730K 0.11% 224
2019
Q3 		$3.33M Buy
13,866
+1,001
+8% +$274K 0.11% 244
2019
Q2 		$3.63M Buy
12,865
+1,819
+16% +$497K 0.12% 247
2019
Q1 		$3.17M Sell
11,046
-4,912
-31% -$1.42M 0.1% 266
2018
Q4 		$4.19M Buy
15,958
+2,107
+15% +$579K 0.15% 209
2018
Q3 		$3.8M Buy
13,851
+4,407
+47% +$1.14M 0.11% 268
2018
Q2 		$2.25M Buy
+9,444
New +$2.19M 0.07% 346

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chartwell Investment Partners's ELV Position: Q3 2024 in Review

Chartwell Investment Partners reduced its Elevance Health (ELV) stake by 20% in Q3 2024, selling an estimated $2.51M and leaving 18,893 shares worth $9.82M. The position accounts for 0.34% of the portfolio, ranked #88.

Chartwell Investment Partners first reported a position in ELV in Q2 2018 and has held it in 26 quarters since. The position peaked at $12.9M in Q1 2024. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Chartwell Investment Partners held 18,893 shares of Elevance Health worth $9.82M as of Q3 2024.
  • Chartwell Investment Partners sold 4,696 Elevance Health shares in Q3 2024, an estimated $2.51M.
  • Elevance Health made up 0.34% of Chartwell Investment Partners's portfolio in Q3 2024, its #88 holding.
  • Chartwell Investment Partners first reported a position in Elevance Health in Q2 2018 and has held it in 26 quarters since.
  • Chartwell Investment Partners's Elevance Health position peaked at $12.9M in Q1 2024.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.